Delivery Order SPE2DB20D2014-SPE2DB24FB96C

Award Date 5/20/24
Potential Completion Date 5/21/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,765.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564671979 - METHYLPHENIDATE ER 36 MG TAB 100S, a pharmaceutical product, with a completion date of May 22, 2024. This award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
This federal contract award, valued at $1,012.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4566491539 METHYLPHENIDATE ER 36 MG TAB 100S, a prescription drug product, with a completion date of November 20, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $3,141.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of METHYLPHENIDATE ER 36 MG TAB 100S, a prescription medication, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,224.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4564712987 ! METHYLPHENIDATE ER 36 MG TAB 100S, a medication, and has an ultimate completion date of May 28, 2024. This contract is a Delivery Order, with a Firm Fixed Price pricing type. The award is not associated with a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of METHYLPHENIDATE ER 36 MG TAB 100S. The contract is a Delivery Order valued at $2,351.53 and has a firm fixed price pricing type. The contract has an ultimate completion date of May 2, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued up...
This federal contract award, valued at $1,456.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of November 15, 2024, for the supply of METHYLPHENIDATE ER 18 MG TAB 100S. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $1,221.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of METHYLPHENIDATE ER 36 MG TAB 100S, a prescription medication, to support military treatment facilities and other federal healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of August 2, 2024. Amerisourcebergen has been...
This federal contract award, valued at $2,637.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4567075758 - METHYLPHENIDATE ER 36 MG TAB 100S, with a performance period through January 29, 2025. The contract is Firm Fixed Price with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $1,192.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of 4564312406 - METHYLPHENIDATE ER 36 MG TAB 100S, a pharmaceutical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award...
This federal contract award, valued at $1,053.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of Methylphenidate ER 36 mg tablets. The contract is a delivery order and utilizes a Firm Fixed Price pricing type. This award appears to be part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FB96C
    Delivery Order

The federal contract award, valued at $2,886.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564712100 - METHYLPHENIDATE ER 36 MG TAB 100S, with a period of performance through May 21, 2024. This contract award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/16/25, 12:30 PM